Immuno-oncology drugs, like immune checkpoint inhibitors (ICIs), have shown potential in treating various cancers. For advanced non-small cell lung cancer (NSCLC) patients with PD-L1 expression of 50% or higher, single-drug ICI therapy that targets PD-L1 is the standard treatment. But can machine le
Did you know that cancer is one of the world’s leading causes of death? In 2020 alone, it took nearly 10 million lives globally, and this number is expected to rise by over 60% by 2040, especially in low- and middle-income countries. One major issue is the lack of proper medical care for cancer pati
Delirium, a sudden change in mental state, is becoming more common in people with cancer at the end of their lives. It's like a sudden confusion that's hard to understand, and it affects their attention and awareness. Doctors know that nurses have important roles in preventing delirium, but how well
Imagine you're a university student in Beirut, Lebanon. You might be surprised to learn that your diet could impact your risk of cancer later in life. A recent study found that many students don't know enough about how food affects cancer prevention. This isn't just about Beirut—Lebanon faces a heav
You might think that cancer treatment ends after the last chemo session or surgery. But the reality is, survivors need ongoing care to stay healthy. That's where virtual follow-ups (VFU) come in. They can make it easier and more convenient for cancer survivors to stay connected with their healthcare
GT103 is a unique human antibody designed to fight cancer by targeting the complement factor H. Scientists conducted a study to test its safety and effectiveness in patients with tough-to-treat lung cancer. The trial involved gradually increasing the drug's dose to find the highest amount that patie
Imagine you're trying to figure out if a certain group of people, like those who worked at the World Trade Center (WTC) after the 9/11 attacks, have a higher chance of getting cancer. You'd compare their cancer rates to another group, right? But which group? That's where things get interesting. A s
Thyroid cancer, particularly Anaplastic Thyroid Cancer (ATC), is known for its aggressiveness and poor prognosis. One key factor influencing this is the tumor immune microenvironment (TIME). To better understand this, scientists used single-cell RNA sequencing (scRNA-seq) to analyze the immune micro
Did you know that how we live and interact within our society can influence whether we get cancer screenings? Research suggests that social factors, like where we live, how much money we have, and who we hang out with, play a part in whether we keep up with recommended cancer screenings. However, ex
You might not think of sugar as a cancer fighter, but tiny sugar molecules, called glycans, are actually crucial for our cells to communicate. They help keep our bodies healthy. But when cancer appears, it messes with these sugar structures. Cancer cells start creating odd sugar formations, called "
